1 |
Mizrahi N, Braun M, Ben GT, et al. Post-transplant diabetes mellitus: incidence, predicting factors and outcomes[J]. Endocrine, 2020, 69(2): 303-309.
|
2 |
Shivaswamy V, Boerner B, Larsen J. Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes[J]. Endocr Rev, 2016, 37(1): 37-61.
|
3 |
Hecking M, Sharif A, Eller K, et al. Management of post-transplant diabetes: immunosuppression, early prevention, and novel antidiabetics[J]. Transpl Int, 2020, 34(1):27-48.
|
4 |
Tnshoff B. Immunosuppressants in organ transplantation[J]. Handb Exp Pharmacol, 2019, 261:441-469.
|
5 |
Xia M, Yang H, Tong X, et al. Risk factors for new-onset diabetes mellitus after kidney transplantation: a systematic review and meta-analysis[J]. J Diabetes Investig, 2020, 12(1): 109-122.
|
6 |
李璐,陈慧真,梁星光,等. 他克莫司致移植后糖尿病发病机制的研究和治疗进展[J/CD]. 中华移植杂志:电子版,2017, 11(1): 44-49.
|
7 |
Dai C, Walker JT, Prasad N, et al. Tacrolimus- and sirolimus-induced human b cell dysfunction is reversible and preventable[EB/OL]. (2020-01-31) [2020-12-01].
URL
|
8 |
Kolic J, Johnson JD. Differential effects of voclosporin and tacrolimus on insulin secretion from human islets [EB/OL]. (2020-08-27) [2020-12-01].
URL
|
9 |
Ling Q, Huang H, Han Y, et al. The tacrolimus-induced glucose homeostasis imbalance in terms of the liver: from bench to bedside[J]. Am J Transplant, 2020, 20(3): 701-713.
|
10 |
Trinanes J, Ten DP, Groen N, et al. Tacrolimus-Induced BMP/SMAD signaling associates with metabolic stress-activated FOXO1 to trigger beta-cell failure[J]. Diabetes, 2020, 69(2): 193-204.
|
11 |
Lim SW, Jin L, Jin J, et al. Effect of exendin-4 on autophagy clearance in beta cell of rats with tacrolimus-induced diabetes mellitus[J]. Sci Rep, 2016, 6: 29921.
|
12 |
Trinanes J, Rodriguez-Rodriguez AE, Brito-Casillas Y, et al. Deciphering tacrolimus-induced toxicity in pancreatic beta cells[J]. Am J Transplant, 2017, 17(11): 2829-2840.
|
13 |
Lombardi A, Trimarco B, Iaccarino G, et al. Impaired mitochondrial calcium uptake caused by tacrolimus underlies beta-cell failure[J]. Cell Commun Signal, 2017, 15(1): 47.
|
14 |
Redmon JB, Olson LK, Armstrong MB, et al. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells[J]. J Clin Invest, 1996, 98(12): 2786-2793.
|
15 |
Hernandez-Fisac I, Pizarro-Delgado J, Calle C, et al. Tacrolimus-induced diabetes in rats courses with suppressed insulin gene expression in pancreatic islets[J]. Am J Transplant, 2007, 7(11): 2455-2462.
|
16 |
Rodriguez-Rodriguez AE, Donate-Correa J, Rovira J, et al. Inhibition of the mTOR pathway: a new mechanism of beta cell toxicity induced by tacrolimus[J]. Am J Transplant, 2019, 19(12): 3240-3249.
|
17 |
Lee S, Moon JY, Lee SH, et al. Angiotensinogen polymorphisms and post-transplantation diabetes mellitus in Korean renal transplant subjects[J]. Kidney Blood Press Res, 2013, 37(2-3): 95-102.
|
18 |
Ditzel J, Lervang HH. Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials[J]. Diabetes Metab Syndr Obes, 2009, 2: 173-177.
|
19 |
Ditzel J, Lervang HH. Disturbance of inorganic phosphate metabolism in diabetes mellitus: its impact on the development of diabetic late complications[J]. Curr Diabetes Rev, 2010, 6(5): 323-333.
|
20 |
Jin J, Lim SW, Jin L, et al. Effects of metformin on hyperglycemia in an experimental model of tacrolimus- and sirolimus-induced diabetic rats[J]. Korean J Intern Med, 2017, 32(2): 314-322.
|
21 |
Chakkera HA, Kudva Y, Kaplan B. Calcineurin inhibitors: pharmacologic mechanisms impacting both insulin resistance and insulin secretion leading to glucose dysregulation and diabetes mellitus[J]. Clin Pharmacol Ther, 2017, 101(1): 114-120.
|
22 |
NCBI. IER3 immediate early response 3[DB/OL]. (2020-08-22) [2020-11-10].
URL
|
23 |
Luo K, Yu JH, Quan Y, et al. Therapeutic potential of coenzyme Q10 in mitochondrial dysfunction during tacrolimus-induced beta cell injury[J]. Sci Rep, 2019, 9(1): 7995.
|
24 |
Cai L, Hu C, Yu S, et al. Identification and validation of a six-gene signature associated with glycolysis to predict the prognosis of patients with cervical cancer[J]. Bmc Cancer, 2020, 20(1): 1133.
|
25 |
Haythorne E, Rohm M, van de Bunt M, et al. Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic beta-cells[J]. Nat Commun, 2019, 10(1): 2474.
|
26 |
Rostambeigi N, Lanza IR, Dzeja PP, et al. Unique cellular and mitochondrial defects mediate FK506-induced islet beta-cell dysfunction[J]. Transplantation, 2011, 91(6): 615-623.
|